Fractional Flow Reserve Implications for Clinical Decision Making in Coronary Artery Disease

Andrei Grib1, Marcel Abras1, Artiom Surev2

  • 1Discipline of Cardiology, State University of Medicine and Pharmacy "Nicolae Testemitanu", MD 2004 Chisinau, Moldova.

Life (Basel, Switzerland)
|October 26, 2024
PubMed

Insights

Fractional flow reserve (FFR) assessment can improve treatment accuracy for coronary artery disease. Visual assessments alone may not align with functional significance, highlighting FFR

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Imaging Analysis

Background:

  • Fractional flow reserve (FFR) is the gold standard for assessing coronary artery lesion significance.
  • Clinical utilization of FFR remains limited despite its proven accuracy.

Purpose of the Study:

  • To compare FFR results with visual angiographic assessments in guiding treatment decisions for coronary artery disease.
  • To evaluate the impact of FFR on interventional cardiology treatment strategies.

Main Methods:

  • Retrospective study of 63 patients with chronic or acute coronary syndrome undergoing FFR assessment.
  • Three experienced interventional cardiologists blinded to FFR results reevaluated 105 ambiguous coronary lesions visually.
  • Treatment decisions (PCI or deferral) were based on angiographic assessment.

Main Results:

  • Visual assessment led to concordant agreement for PCI in 57.1% of lesions, but 15% were functionally non-significant by FFR.
  • PCI was deferred in 42.9% of lesions, yet 8.9% were functionally significant by FFR and required re-evaluation.
  • Significant discrepancies exist between visual assessment and FFR-determined functional significance.

Conclusions:

  • Visual assessment of coronary lesions by interventional cardiologists shows variability and does not consistently align with FFR.
  • Incorporating FFR into routine clinical decision-making can enhance treatment accuracy for coronary artery disease.
  • Utilizing FFR may lead to improved patient outcomes in managing coronary artery disease.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
1
Coronary Artery Disease V: Surgical Management01:27

Coronary Artery Disease V: Surgical Management

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
1
Coronary Artery Disease IV: Medical Management01:26

Coronary Artery Disease IV: Medical Management

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
3
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
3